Functional similarities of human and chicken apolipoprotein A-I: Dependence on secondary and tertiary rather than primary structure

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1531, Issue 3, 2001, Pages 251-259

  Kiss, Robert S ^a   Ryan, Robert O ^a   Francis, Gordon A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apolipoprotein; Cholesterol; Efflux; High density lipoprotein; Sequence

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE C R; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; CHICKEN; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ESTERIFICATION; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PARTICLE SIZE; PHOSPHOLIPID BILAYER; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN LIPID INTERACTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; CELLS, CULTURED; CHICKENS; CHOLESTEROL; FIBROBLASTS; HUMANS; LIPID BILAYERS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASE C; PHOSPHOLIPIDS; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 0035971639     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(01)00109-3     Document Type: Article

References (50)

1. Rubins H.B., Robins S.J., Iwane M.K., Boden W.E., Elam M.B., Fye C.L., Gordon D.J., Schaefer E.J., Schectman G., Wittes J.T. Rationale and design of the Department of Veterans Affairs high density lipoprotein intervention trial (HIT) for secondary prevention of coronary artery disease in men with low high density lipoprotein cholesterol and desirable low density lipoprotein cholesterol. Am. J. Cardiol. 71:1993;45-52.
2. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
3. Oram J.F., Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37:1996;2473-2491.
4. Rothblat G.H., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40:1999;781-796.
5. Fielding P.E., Fielding C.J. A cholesteryl ester transfer complex in human plasma. Proc. Natl. Acad. Sci. USA. 77:1980;3327-3330.
6. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
7. Ji Y., Jian B., Wang N., Sun Y., de la Llera Moya M., Phillips M.C., Rothblat G.H., Swaney J.B., Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272:1997;20982-20985.
8. Xu S., Laccotripe M., Huang X., Rigotti A., Zannis V.I., Krieger M. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38:1997;1289-1298.
9. Holvoet P., Zhao Z., Vanloo B., Vos R., Deridder E., Dhoest A., Taveirne J., Brouwers E., Demarsin E., Engelborghs Y., Rosseneu M., Collen D., Brasseur R. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. Biochemistry. 34:1995;13334-13342.
10. Davidson W.S., Hazlett T., Mantulin W.W., Jonas A. The role of apolipoprotein AI domains in lipid binding. Proc. Natl. Acad. Sci. USA. 93:1996;13605-13610.
11. Laccotripe M., Makrides S.C., Jonas A., Zannis V.I. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J. Biol. Chem. 272:1997;17511-17522.
12. Gillotte K.L., Zaiou M., Lund-Katz S., Anantharamaiah G.M., Holvoet P., Dhoest A., Palgunachari M.N., Segrest J.P., Weisgraber K.H., Rothblat G.H., Phillips M.C. Apolipoprotein-mediated plasma membrane microsolubilization. J. Biol. Chem. 274:1999;2021-2028.
13. Ji Y., Jonas A. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins. J. Biol. Chem. 270:1995;11290-11297.
14. Sviridov D., Pyle L.E., Fidge N. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants. J. Biol. Chem. 271:1996;33277-33283.
15. Sviridov D., Pyle L., Fidge N. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. Biochemistry. 35:1996;189-196.
16. Kiss R.S., Ryan R.O., Hicks L.D., Oikawa K., Kay C.M. Physical properties of apolipoprotein A-I from the chicken, Gallus domesticus. Biochemistry. 32:1993;7872-7878.
17. Kiss R.S., Kay C.M., Ryan R.O. Amphipathic alpha-helix bundle organization of lipid-free chicken apolipoprotein A-I. Biochemistry. 38:1999;4327-4334.
18. Formisano S., Brewer H.B.J., Osborne J.C.J. Effect of pressure and ionic strength on the self-association of Apo-A-I from the human high density lipoprotein complex. J. Biol. Chem. 253:1978;354-359.
19. Edelstein C., Scanu A.M. Effect of guanidine hydrochloride on the hydrodynamic and thermodynamic properties of human apolipoprotein A-I in solution. J. Biol. Chem. 255:1980;5747-5754.
20. Jackson R.L., Lin H.U., Chan L., Means A.R. Isolation and characterization of the major apolipoprotein from chicken high density lipoprotein. Biochim. Biophys. Acta. 420:1976;342-349.
21. Chung B.H., Wilkinson T., Greer J.C., Segrest J.P. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J. Lipid Res. 21:1980;284-291.
22. Yokoyama S., Tajima S., Yamamoto A. Process of dissolving apolipoprotein A-I in an aqueous buffer. J. Biochem. 91:1982;1267-1272.
23. Wientzek M., Kay C.M., Oikawa K., Ryan R.O. Binding of insect apolipophorin III to dimyristoylphosphatidylcholine vesicles. Evidence for a conformational change. J. Biol. Chem. 269:1994;4605-4612.
24. Ryan R.O., Schieve D., Wientzek M., Narayanaswami V., Oikawa K., Kay C.M., Agellon L.B. Bacterial expression and site-directed mutagenesis of a functional recombinant apolipoprotein. J. Lipid Res. 36:1995;1066-1072.
25. Nelson C.A., Lee J.A., Brewster M., Morris M.D. Flotation equilibrium of serum low density lipoproteins. Anal. Biochem. 59:1974;69-74.
26. Swaney J.B., O'Brien K. Cross-linking studies of the self-association properties of apo-A-I and apo-A-II from human high density lipoprotein. J. Biol. Chem. 253:1978;7069-7077.
27. Liu H., Scraba D.G., Ryan R.O. Prevention of phospholipase-C induced aggregation of low density lipoprotein by amphipathic apolipoproteins. FEBS Lett. 316:1993;27-33.
28. Brinton E.A., Oram J.F., Chen C.H., Albers J.J., Bierman E.L. Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. J. Biol. Chem. 261:1986;495-503.
29. Francis G.A., Oram J.F., Heinecke J.W., Bierman E.L. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry. 35:1996;15188-15197.
30. Oram J.F., Mendez A.J., Slotte J.P., Johnson T.F. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not plasma membranes of cholesterol-loaded fibroblasts. Arterioscler. Thromb. 11:1991;403-414.
31. Hara A., Radin N.S. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 90:1978;420-426.
32. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
33. Brouillette C.G., Anantharamaiah G.M. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta. 1256:1995;103-129.
34. Wald J.H., Krul E.S., Jonas A. Structure of apolipoprotein A-I in three homogeneous, reconstituted high density lipoprotein particles. J. Biol. Chem. 265:1990;20037-20043.
35. Das S., Rand R.P. Modification by diacylglycerol of the structure and interaction of various phospholipid bilayer membranes. Biochemistry. 25:1985;2882-2889.
36. Siegel D.P., Banschbach J., Alford D., Ellens H., Lis L.J., Quinn P.J., Yeagle P.L., Bentz J. Physiological levels of diacylglycerols in phospholipid membranes induce membrane fusion and stabilize inverted phases. Biochemistry. 28:1989;3703-3709.
37. Suits A.G., Chait A., Aviram M., Heinecke J.W. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam cell formation. Proc. Natl. Acad. Sci. USA. 86:1989;2713-2717.
38. Wishart D.S., Boyko R.F., Willard L., Richards F.M., Sykes B.D. SEQSEE: a comprehensive program suite for protein sequence analysis. Comput. Appl. Biosci. 10:1993;121-132.
39. Callebaut I., Labesse G., Durand P., Poupon A., Canard L., Chomilier J., Henrissat B., Mornon J.P. Deciphering protein sequence information through hydrophobic cluster analysis (HCA) current status and perspectives. Cell. Mol. Life Sci. 53:1997;621-645.
40. Borhani D.W., Rogers D.P., Engler J.A., Brouillette C.G. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94:1997;12291-12296.
41. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipid by apolipoprotein A-1 in Tangier disease. J. Clin. Invest. 96:1995;78-87.
42. Wang W.Q., Merriam D.L., Moses A.S., Francis G.A. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J. Biol. Chem. 273:1998;17391-17398.
43. Francis G.A., Mendez A.J., Bierman E.L., Heinecke J.W. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc. Natl. Acad. Sci. USA. 90:1993;6631-6635.
44. Remaley A.T., Schumacher U.K., Stonik J.A., Farsi B.D., Nazih H., Brewer H.B. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17:1997;1813-1821.
45. Francis G.A., Perry R.J. Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis. Clin. Chim. Acta. 286:1999;219-230.
46. Young S.G., Fielding C.J. The ABCs of cholesterol efflux. Nat. Genet. 22:1999;316-318.
47. Hara H., Hara H., Komaba A., Yokoyama S. Alpha-helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids. 27:1992;302-304.
48. Hara H., Yokoyama S. Interaction of free apolipoproteins with macrophages. J. Biol. Chem. 266:1991;3080-3086.
49. Mendez A.J., Anantharamaiah G.M., Segrest J.P., Oram J.F. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94:1994;1698-1705.
50. Yancey P.G., Bielicki J.K., Johnson W.J., Lund-Katz S., Palgunachari M.N., Anantharamaiah G.M., Segrest J.P., Phillips M.C., Rothblat G.H. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and Class A amphipathic peptides. Biochemistry. 34:1995;7955-7965.